Analysts at Intron Health, led by Naresh Chouhan, suggested that Friday’s market reaction was excessively severe.
Novo Nordisk Rises 5% In Premarket As Analyst Dismisses Friday’s 17% Plunge As Market Overreaction
Where Today's News Shapes Tomorrow
